{"id":"NCT00335283","sponsor":"Vanderbilt University","briefTitle":"Efficacy of Lansoprazole in Chronic Post Nasal Drip","officialTitle":"Randomized Placebo-Controlled Trial of BID Lansoprazole in Isolated Chronic Post Nasal Drip","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-08","primaryCompletion":"2008-12","completion":"2008-12","firstPosted":"2006-06-09","resultsPosted":"2012-08-21","lastUpdate":"2012-08-21"},"enrollment":75,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Larynx Disease"],"interventions":[{"type":"DRUG","name":"Lansoprazole Tablet","otherNames":["prevacid"]},{"type":"PROCEDURE","name":"PH and impedence testing","otherNames":[]},{"type":"PROCEDURE","name":"manometry","otherNames":[]},{"type":"DRUG","name":"lansoprazole","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"Lansoprazole","type":"ACTIVE_COMPARATOR"},{"label":"Sugar Pill","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether aggressive acid suppression with Lansoprazole is effective in the treatment of post nasal drip, and also assess the predictors of response based on clinical and physiologic parameters.","primaryOutcome":{"measure":"Post Nasal Drainage Symptom Response","timeFrame":"8 and 16 weeks","effectByArm":[{"arm":"Lansoprazole","deltaMin":55,"sd":null},{"arm":"Placebo (Sugar Pill)","deltaMin":3.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":".01"},{"comp":"OG000 vs OG001","p":".006"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":11},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":36},"commonTop":[]}}